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 Formalin-fi xed paraffi n-embedded (FFPE) 
samples represent a valuable under-
exploited resource for large, retrospective 
and prospective studies with long-term 
clinical follow-up   [1] . The existence of 
FFPE samples collections worldwide, and 
their advantages such as easy handling, 
long-term inexpensive storage, suitability 
for immunohistochemical analyses, and 
low-cost of large-scale application, make 
this type of storage a relevant option  [2] . 
 The primary goal of formalin fi xation 
is preserving cellular structure for histo-
logical examination and diagnosis, so some 
challenges arise regarding the suitability 
of genetic material extracted from FFPE 
samples for molecular testing  [3] . 
 Many factors during the fi xation process 
infl uence nucleic acids conditions. Such as, 
at the pre-fi xation step, the type and amount 
of tissue or the time elapsed from surgery 
to fi xation. At the fi xation step, this could 
be the type of fi xative, temperature, pH or 
duration. At the post-fi xation step, it could 
be the storage time and conditions  [2] . 
 The effects on the genetic material 
include cross-linking, which decreases 
the effi cacy of posterior PCR  [3] . Hence, 
steps must be taken to improve the use of 
FFPE in molecular testing, especially those 
factors affecting downstream techniques, 
because this will permit the reevaluation of 
stored FFPE samples independently of their 
origin  [4] . 
 Recently, one of the most commonly 
used downstream techniques is NGS, which 
allows sequencing multiple cancer-related 
genes in a high-throughput manner  [5] . 
Despite the tested use of FFPE tissue in 
NGS  [6] , further studies are required to 
check whether archival FFPE samples are 
suitable for NGS  [7, 8] . A recent study found 
that FFPE samples stored for more than 
7 years were not worth being included in 
NGS studies  [9] . 
 It would be helpful to have predictive 
quality indicators to know whether samples 
are suitable for NGS. This would avoid 
wasting precious samples that could 
undergo alternative molecular studies if 
not suitable for NGS, an as-yet expensive 
molecular approach. 
 In this context, there are parameters to 
elucidate the quality of the genetic material 
from FFPE samples. Among others, DNA 
integrity number (DIN) and RNA integrity 
number (RIN) from Agilent Technologies 
(CA, USA), in a range of 1 to 10, give infor-
mation regarding the fragmentation of 
the DNA or RNA based on electropho-
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resis [10,11]. Also, the quality control (QC) 
value from Illumina (CA, USA) enables the 
researcher to test the quality of the DNA 
based on a qPCR, giving values closer to 
zero when the quality is the highest [12,13].
Our aim was to evaluate the suitability of 
melanoma FFPE samples for an amplicon-
based NGS custom panel analysis 
according to the storage time, type of 
sample, QC and DIN values.
Materials & methods
Sample collection
FFPE blocks came from the Biobank at 
the Instituto Valenciano de Oncología 
(Valencia, Spain). A cohort of 59 samples 
were analyzed including 37 primary 
melanoma tumors and 22 wide local 
excision tissues retrieved and stored at the 
Pathological Anatomy Department from 
January 2000 to April 2017. Therefore, 
the time elapsed from the surgery (time 
of storage) was up to 17 years and the 
distribution was made based on a CART 
analysis regarding the library functionality 
(see below): 42.4% of the samples were 
referred to as ‘old’ (>7 years) and 57.6% of 
the samples were referred to as ‘recent’ 
(≤7 years). The time of sample fixation in 
formalin solution was estimated based on 
the date of the surgery when the sample 
was taken. Two categories were defined: 
<1 day (usually overnight fixation), when 
the day after the surgery was a work day 
and >1 day when it was a holiday (usually 
>1–2 days).
This study took place as part of a 
bigger project that had the approval of the 
Ethics Committee at the Instituto Valen-
ciano de Oncología, and patients signed 
a voluntary cession of the samples to the 
Biobank.
The main outcome variable was the 
functionality of the sample, which was 
defined as the ability of a sample to 
construct an amplicon-based library with 
a length of 300–350 bp, visible as a single 
band on an electrophoresis test.
FFPE processing
The Pathological Anatomy Department of 
our center had a standardized protocol for 
the processing of FFPE samples. A first 
formalin fixation of the sample was followed 
by the block preparation procedure. 
This was performed in the Excelsior ES 
automatic processor (ThermoScientific, 
CA, USA) and included a formalin fixation-
step (30 min), an increasing multiple-step 
dehydration (9 h 45 min), a triple clearing 
step with xylene (2 h 15 min), and a final 
three-step embedding in paraffin wax 
(4 h). Then, blocks were kept at room 
temperature at the Biobank.
DNA isolation & quantification
From each FFPE block, a 3-μm section 
was used for hematoxylin and eosin (H&E) 
stain. Then, a pathologist evaluated and 
selected the area with tumor-enriched 
cells for macrodissection. Using the 
H&E slide as a reference, three 0.6-mm 
needle biopsies were taken from every 
primary tumor. For the wide local excision 
tissue, three 10-μm sections were cut and 
collected into 1.5-ml tube (Eppendorf).
DNA was extracted using the QIAamp® 
DNA Investigator kit (QIAGEN, Hilden, 
Germany), with the following modifica-
tions: given the toughness of the skin, 
we established an overnight incubation 
at 56°C for the proteinase K to assure a 
complete digestion. Also, we introduced 
the optional carrier addition to maximize 
the extraction yield.
Quantification was obtained using 
Quant-iT™ PicoGreen™ dsDNA Assay 
kit (Invitrogen, MA, USA). All samples had 
a concentration above 2.5 ng/μl and were 
accepted for the study.
DNA reparation
The NEBNext® FFPE Repair Mix (New 
England Biolabs, Hertfordshire, UK) kit 
was used to repair the C:G > T:A changes 
induced by nucleotide deamination, 
usually present in FFPE samples.
Quality assessment tests
Real-time PCR was performed using 1X 
Sybr Green PCR Master Mix (Applied 
Biosystems) and FFPE QC Kit (Illumina) 
following the manufacturer’s instruc-
tions. Briefly, 2 μl of diluted DNA (1:100) 
was added to 8 μl of the mix containing 
SybrGreen and Illumina primers. All runs 
were processed in an ABI7500 Fast PCR 
system (Applied Biosystems) using the 
default run protocol: 50°C/2 min–95°C/10 
min–40 cycles of 95°C/30 s, 57°C/30 s, 
72°C/30 s). All reactions were performed 
in triplicates. The resulting QC value was 
an indicator of the sample quality, with a 
lower value being the better the quality 
indicator.
Gel electrophoresis was performed 
using Genomic DNA ScreenTape in a 
4200 TapeStation (Agilent Technologies). 
Briefly, 1 μl of DNA and 3 μl of sample 
buffer were added to each well.
DIN value obtained was an indicator of 
the integrity of the DNA, thus a higher DIN 
value meant a better quality.
Library construction
Low input DNA libraries of the gene 
panel containing 21 melanoma-related 
genes were constructed according to 
the manufacturer’s instructions using 
a custom GeneRead DNAseq Panel 
(QIAGEN). Shortly, DNA fragments were 
amplified in a multiplex PCR to obtain a 
total of 633 amplicons of 200 bp in length 
(GeneRead DNAseq Panel PCR kit V2 
Qiagen). At this point, a normalization step 
was included and 100 ng of each sample 
continued the process. The ends of the 
molecules were enzymatically repaired 
and universal adaptors were ligated, then 
unique combinations of MID adaptors 
were ligated (NEBNext Ultra DNA Library 
Prep Kit, New England Biolabs).
Library functionality
Final library size was checked with a 
bioanalyzer using D1000 DNA ScreenTape 
(Agilent Technologies). The final amplicon 
size including the MID adapters made an 
average of 350 bp. Thus, the presence of 
a single band in the range of 300–350 bp 
classified the library as functional.
Statistical analysis
The statistics were performed using 
IBM SPSS Statistics 20.0. Normal 
distribution of continuous variables 
was checked using the Kolmogorov–
Smirnov test. Pearson test was used to 
study the correlation among parametric 
variables and Spearman test was used 
for non-parametric variables. A 1-factor 
ANOVA test was used to compare means 
of continuous variables and qualitative 
ones. Also, continuous variables were 
categorized with a CART analysis using 
library functionality as a filter. Diagnostic 
parameters, including sensitivity, speci-
ficity, predicted positive and negative 
value, accuracy, and area under the 
curve from a ROC test were calculated 
to evaluate the capacity of each parameter 
or algorithm to predict library functionality.
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Results & discussion
The study included a total of 59 unpaired 
FFPE samples corresponding to 37 
melanoma primary tumors and 22 
unmatched wide local excision tissues 
stored for a median of 5 years (range: 1–17 
years). The characteristics of the samples 
are displayed in Table 1.
Influence of date of surgery 
on library functionality
There was a great variability in library 
yield independent of the tissue origin 
or the time of storage, despite the 
existence of a normalization step to 
include 100 ng in the end reparation 
step. A 1-factor ANOVA test showed that 
the mean storage time was significantly 
lower in samples with functional library 
than in samples with non-functional 
library (4.93 vs 9.49 years, respectively; 
p < 0.001). The best cut-off that differ-
entiated functional from non-functional 
samples was established at 7 years 
by CART analysis, and recent samples 
(≤7 years) showed a significantly higher 
percentage of library functionality than 
old samples (>7 years; 70.6 vs 20%; p 
< 0.001) (Figure 1A). The fixation time did 
not influence the f unctionality (Table 1). 
QC & DIN values as q uality 
predictor parameters
QC values were inversely correlated with time 
of storage (r = -0.616; p < 0.001) (Figure 1B) 
and library functionality (rs  =  -0.334; 
p = 0.009). A 1-factor ANOVA test showed 
that QC means were s tatistically different 
between functional and non-functional 
samples (4.03 vs 5.7; p = 0.002).
According to the CART analysis, cut-off 
value for QC was established at 5.63 (93.1% 
of samples with a QC ≤ 5.63 produced 
functional libraries compared with 6.9% 
of samples with a QC > 5.63; p = 0.004) 
(Figure 1C).
DIN values showed a direct correlation 
with the time of storage (r = 0.523; p < 0.001) 
(Figure 1D), as well as with library function-
ality (rs = 0.319; p = 0.016). We established a 
cut-off for DIN value at 2.05 based on CART 
analysis, and results showed that DIN values 
greater than 2.05 gave functional libraries 
in a higher proportion than those less than 
or equal to 2.05 (82.1 vs 17.9%; p = 0.023) 
(Figure 1E). As expected, QC and DIN were 
inversely correlated (r = -0.535; p < 0.001) 
(Figure 1F).
When looking at the possible differ-
ences between tumor tissue and wide 
local excision samples within old and 
recent groups, it was found that for the old 
cohort, lower QC values were more frequent 
in tumor samples (13/14; 92.9%) than in 
wide local excision samples (1/14; 7.1%; 
p = 0.009). No difference was found for DIN 
or functionality in this group. For the recent 
cohort, functional libraries corresponded in 
a higher proportion to the wide local excision 
(15/24; 62.5%) rather than tumor samples 
(9/24; 37.5%). No difference was found for 
DIN or QC in this group.
Convergence of  parameters 
in a decision tree
Time of storage, QC and DIN were simulta-
neously assessed by CART test to analyze 
their impact on the library functionality, and 
a decision tree was developed (Figure 2). 
The storage time was the parameter that 
better discriminated the library functionality. 
Samples stored for 7 years or less gave 
functional libraries in 70.6% of the cases. 
For samples stored for more than 7 years 
the value of QC in the first place, and of DIN 
in the second place, discriminated samples 
by their functionality. Thus, samples with QC 
less than or equal to 5.63 and DIN greater 
than 2.05, allowed identification of a group 
with 44% of functional libraries. 
The diagnostic parameters were 
evaluated for each variable individually and 
for the algorithm obtained by CART analysis. 
The latter was also evaluated only for the 
oldest samples (Table 2).
The decision tree provided better 
values in the diagnostic parameters (sensi-
tivity = 91.3%; specificity = 72.9; predicted 
positive values  =  65.1%; predicted 
negative values = 93.8; accuracy = 79.5%; 
ROC area under the curve = 0.733) than 
each parameter individually. In addition, 
the decision tree restricted to the old 
samples also showed acceptable figures 
(ROC = 0.78).
There are several studies in the literature 
that have evaluated QC and DIN/RIN values 
prior to NGS [11]. Yakovleva et al. estab-
lished in 2017 a cut-off of RIN of > 2.00 
for using FFPE samples in downstream 
processes [10].  Similarly, Bonfiglio et al. 
proposed in 2016 the use of a DIN cutoff 
at 3.0  [13]. All these previous studies agree 
with our findings, but all of them used 
FFPE samples that had been stored for a 
maximum of 6 years. Hence, we contribute 
Table 1. Sample distribution according to their final library functionality.
  Total Functional Non-functional p-value
  N % N % N %  
QC       
QC ≤ 5.63 45 76.2 27 93.1 18 60 0.005
QC > 5.63 14 23.7 2 6.9 12 40  
DIN  
DIN ≤ 2.05 19 33.9 5 17.9 14 50 0.023
DIN > 2.05 37 66.1 23 82.1 14 50  
Time of storage  
Old 25 51 5 17.2 20 66.7 <0.001
Recent 34 57.6 24 82.8 10 33.3  
Fixation time  
<1 day 25 44.6 15 51.7 10 33.3 0.3
≥1 day 11 19.6 5 17.2 6 20  
Not available 20 35.7 8 27.6 12 40  
p-value by Chi-squared test. DIN: DNA integrity value; N: Number; QC: Quality control.
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valuable information regarding samples 
stored for longer periods, with a functional 
analysis on constructed amplicon-based 
libraries and not only on genomic DNA. 
These findings suggest that older FFPE 
samples should preferably be used for 
pathological analysis and molecular tests 
that do not require such quality starting 
material.
A flow-chart proposal was developed 
including all variables to determine the 
best approach when working with FFPE 
samples, taking into consideration the 
quality parameters QC and DIN as well as 
the time of storage (Figure 2). A deeper 
analysis of the diagnostic parameters 
of this proposal pointed out the utility of 
our approach given its accuracy of up to 
79.5%. This could be translated into the 
practical work and suggests that, if willing 
to have a small percentage of compromise, 
all recent samples could be used. Then, 
only by using the QC value as a predictor 
parameter, those samples stored for >7 
years could be included if their QC is ≤ 
5.63 with an expected adequate function-
ality in 35.7% of samples. The use of the 
DIN value would increase the specificity 
in those studies where genetic material is 
precious and must be highly optimized and 
the expected adequate functionality could 
be increased up to 44.4% of the samples.
This study has demonstrated that 
QC (≤5.63) and DIN (>2.05) are able to 
discriminate between functional and 
non-functional samples beyond storage 
time, particularly for old samples. It showed 
that QC and DIN were appropriate quality 
parameters, for which values differed 
between old and recent samples, and 
between functional and non-functional 
libraries. On the other hand, differences 
were found in QC between tumor samples 
and wide local excision samples, although 
they were not relevant for functionality in 
old samples. In recent samples, wide 
local excision samples worked better 
than tumors in terms of functionality, which 
might be explained by the role of melanin 
in tumor samples, which can lead to 
inhibition of PCR due to the association of 
remnants of pigment melanin with genomic 
DNA [14,15].
The strengths of this study include 
the performance over amplicon-based 
libraries instead of genomic DNA, as seen 
in previous studies. Also, the results can be 
extrapolated to different approaches. As 
a limitation, the modest size of the cohort 
should be highlighted, so future studies 
must corroborate these findings.
In conclusion, the storage time was the 
most important variable that influenced 
sample viability for amplicon-based library 
construction. The addition of QC and DIN 
helped refine the rate of samples suitable 
for NGS and particularly to identify which 







































































































Figure 1. Statistical analysis. Here are presented the graphical distribution of failed (white) and functional 
(gray) libraries for the different variables (Date of surgery, QC threshold and DIN threshold) (A, C, E). Also, the 
correlations studied between QC and date of surgery (B), DIN and date of surgery (D), and QC and DIN (F). 
DIN: DNA integrity value; QC: Quality control.
Table 2. Diagnostic test parameters for each variable and the algorithm obtained by CART analysis.
  S (%) SP (%) PPV (%) PNV (%) A (%) ROC (AUC)
QC  80.8 68.2 60.0 85.7 72.9 0.33
DIN 70.3 66.1 62.2 73.7 68.0 0.66
Time of storage 77.9 73.1 70.6 80.0 75.3 0.75
CART† 91.3 72.9 65.1 93.8 79.5 0.73
CART (for old samples)‡ 87.7 62.8 44.4 93.8 69.1 0.78
‘CART’ includes the results for the diagnostic parameters of the proposed flowchart obtained by CART analysis.
†Positive for the test if date of surgery < 7 years or if QC ≤ 5.63 and DIN > 2.05.
‡Only for old samples, with a date of surgery > 7 years. Positive if QC ≤ 5.63 and DIN > 2.05  
A: Accuracy; PNV: Predicted negative values; PPV: Predicted positive values; QC: Quality control; S: Sensitivity; SP: Specificity.
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